Clarivate Report Demonstrates Societal Impact of Digital Health Research and Innovation Growth

June 27, 2024 03:45 PM IST | By Cision
 Clarivate Report Demonstrates Societal Impact of Digital Health Research and Innovation Growth
Image source: Kalkine Media

LONDON, June 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released a Global Research Report from the Institute for Scientific Information (ISI)™. The report integrates and interprets multiple data sources from across Clarivate™ portfolios to highlight the academic and societal benefits of the rapidly evolving landscape of digital health.

Research impact in society and the economy: The digital health revolution in medical care highlights a rapid growth in both research and patent activity around digital health. It identifies the leading global players and organizations and their collaborations, alongside emerging companies with potential impact. By combining data from the Web of Science™ and Derwent World Patents Index™, experts at the ISI and the newly established Clarivate Center for IP and Innovation Research™ provide a comprehensive analysis of the digital health space. The analysis is presented alongside a taxonomy to categorize it into major fields, developed by analysts from the Life Sciences & Healthcare segment at Clarivate.

This study builds on a recent collaboration with Times Higher Education and initial findings were presented at Digital Health 2024, an industry-wide event held at Stanford University in February 2024. 

Digital health encompasses the use of digital technologies, such as mobile apps, wearables and telemedicine, to improve health and healthcare delivery. The anticipated societal benefits of accessing and utilizing digital health include improving access to and the quality of medical care, enabling more personalized care with greater patient involvement and commitment, fostering a shift towards preventive rather than reactive care, streamlining healthcare delivery and reducing costs. 

David Pendlebury, Head of Research Analysis at the Institute for Scientific Information at Clarivate and co-author of the report, said: "We are witnessing a surge in digital health research and innovation, highlighted by the significant growth in academic publications and patent filings. The outputs of this study will appeal to those interested in the future of healthcare technology and its societal impact, providing a valuable foundation for informed decision-making in this dynamic field for academic institutions, corporate entities and government bodies." 

Key findings include: 

  • Significant growth in digital health publications: There has been a nearly 70-fold increase in academic papers featuring the term digital health in the decade to 2022, reflecting a major shift towards the integration of digital technologies in healthcare. This has been recently driven by advances in artificial intelligence (AI) and advanced analytics, predating the popularization of AI technologies such as ChatGPT.
  • Rapid increase in digital health patenting activity: Patenting activity in digital health has outpaced the growth in publications, with approximately 140,000 patent inventions identified from 2013 to 2022 – indicating robust efforts within the industry to secure intellectual capital and gain market advantage. 
  • Corporate dominance in patenting: Our analysts highlight an eclectic mix of organizations, side-by-side within one patent analysis — Snap and AstraZeneca, Nike and Johnson & Johnson or Eli Lilly and Nvidia — demonstrating the convergent and collaborative nature of the field of digital health. 
  • Strength of AI patenting in digital health: Mainland China, represented by the Chinese Academy of Sciences, universities and corporations, plays a pivotal role in this field.
  • Impact of university research on digital health innovation: University research significantly influences digital health innovation, with research papers frequently cited by patents, highlighting their role in driving intellectual property advancements. 

Emmanuel Thiveaud, Senior Vice President of Research and Analytics, Academia & Government at Clarivate said: "At Clarivate, our transformative intelligence seamlessly integrates enriched data, insightful analytics, workflow solutions and profound domain expertise across the entire spectrum of knowledge, research, health and innovation. We have combined them to demonstrate that digital health is a fundamental shift in how healthcare is delivered and experienced. By leveraging comprehensive data resources and expert analysis, stakeholders can develop strategies that maximize both academic benefits and societal impact." 

About Clarivate 
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com.  

Media contact:
Rebecca Krahenbuhl, Senior Manager, External Communications, Academia & Government
[email protected]   


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

Recent Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.